2897. Collocated Buprenorphine Is Associated with Improved HCV Visit Adherence in People Who Inject Drugs (PWID): Data From the ANCHOR Study

BACKGROUND: Engaging PWID in HCV treatment and monitoring for reinfection is critical to eliminate HCV and improve health in people who use drugs. However, PWID are often marginalized and can be difficult to engage and retain in care. The collocation of HCV treatment with buprenorphine to treat opio...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Forum Infect Dis
Auteurs principaux: Rosenthal, Elana S, Silk, Rachel, Mathur, Poonam, Eyasu, Rahwa, Nussdorf, Laura, Hill, Kristi, D’Amore, Aaron, Brokus, Christopher, Bijole, Phyllis, Jones, Miriam, Kier, Randy, Sternberg, David, Masur, Henry, Kottilil, Shyam, Kattakuzhy, Sarah
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6808822/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz359.175
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires